News Digest / Ticker: CVS

Ticker: CVS

07:17am, Wednesday, Jun 17, 2026
Rising hormone replacement therapy demand is squeezing US progesterone supplies, causing intermittent shortages of oral progesterone amid broader menopause treatment challenges and growing prescriptions since FDA warning removal in 2025.